Bladder Cancer | Tumor

CURE’s bladder cancer page is a go-to resource for oncology news and updates in the world of bladder cancer. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in bladder cancer.

Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer

February 1st 2023

The first patient was dosed with lerapolturev in a phase 1/2 clinical trial evaluating the drug in patients with bladder cancer and other solid tumors.

Cancer Is Like a Race, and I’m Determined to Win

January 25th 2023

Cancer — and its treatments — can feel like a grueling race, but I’m using frequent follow-ups and an excellent care team to stay ahead of the game.

FDA Is Speeding Up Review of Padcev-Keytruda Combo for Bladder Cancer

January 17th 2023

The Food and Drug Administration is speeding up the review and potential approval of Padcev plus Keytruda for certain patients with urothelial carcinoma, the most common form of bladder cancer.

Smoking May Double Risk for Recurrence in Some Patients With Bladder Cancer

January 2nd 2023

Patients with non-muscle invasive bladder cancer who currently smoke or previously smoked should consider quitting to possibly improve health outcomes in survivorship, according to an expert.

FDA Approves First Gene Therapy for Non-Muscle Invasive Bladder Cancer

December 16th 2022

Adstiladrin represents the first gene therapy approved by the FDA for the treatment of patients with high-risk non-muscle invasive bladder cancer who are resistant to BCG, the first-line standard of care for these patients.

Smoking History and Habits May Increase Bladder Cancer Recurrence Risk, Study Finds

December 15th 2022

Patients with non-muscle invasive bladder cancer who smoke should consider quitting to possibly improve health outcomes in survivorship, according to an expert.

Type of Surgery for Bladder Cancer May Impact Sexual Function

December 14th 2022

Sexual dysfunction is not less common in women with bladder cancer who undergo reproductive organ-sparing radical cystectomy, although more research is needed.

Even a 'Tough Guy' Can Open Up About Cancer

December 12th 2022

Men often decide to tough out their cancer alone, but tough guy Terry Bradshaw is starting to open up about his sometimes-rocky journey with the disease.

Cancer Survivor Throws Out World Series First Pitch, Dwayne ‘The Rock’ Johnson Sends Best Wishes to Child With Brain Cancer and More

November 4th 2022

From a childhood cancer survivor throwing out the first pitch at Game 4 of the World Series to former WWE champion and actor Dwayne “The Rock” Johnson recording a message for a child with brain cancer, here’s what’s happening in the cancer space this week.

End-of-Life Discussions Can ‘Lay Out a Roadmap’ of Patient Wishes and Avoid Unnecessary Cancer Care

November 2nd 2022

Talking about the end of life can be difficult, but these conversations are crucial for patients with incurable cancer to have with their clinicians, experts say.

Standup Comedian and Self-Proclaimed 'Love Goddess' Judy Tenuta Dies From Cancer, New England Patriots Host a ‘Day of Pampering’ for Cancer Survivors and More

October 7th 2022

From the death of standup comedian and "Love Goddess" Judy Tenuta to professional sports hall-of-famers discussing their cancer, here’s what’s happening in the cancer space this week.

Living Well Beyond Bladder Cancer With Support

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about support available for patients and caregivers following a bladder cancer diagnosis.

Expert Discusses Effects of a Bladder Cancer Diagnosis on Caregivers and the Support Available to Them

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about the role of the caregiver in bladder cancer and how they can also seek support to aid them.

Patients Can Help Move the Needle Forward in Bladder Cancer Clinical Trials With Participation

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about how patients can find clinical trials they may be eligible for.

Having Open and Honest Conversations With Oncologists Aids in Patient-Physician Communication in Bladder Cancer

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about letting physicians know about patient preferences to improve communication and select the right treatment option.

Combining Old and New Therapies in Advanced Bladder Cancer Shows Promise for the Future

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about how currently available agents are being investigated in combination with one another.

Chemoradiotherapy May Provide Long-Term Survival Benefit for Muscle-Invasive Bladder Cancer

September 19th 2022

Long-term outcomes from this trial confirm the benefit of treatment with chemoradiotherapy over chemotherapy alone for patients with muscle-invasive bladder cancer.

Enrollment Opens for Trial Evaluating Abelacimab for Blood Clots From Gastrointestinal, Genitourinary Cancers

August 26th 2022

The phase 3 MAGNOLIA trial will assess whether abelacimab can prevent venous thromboembolism recurrence in patients with gastrointestinal or genitourinary cancers.

Padcev Plus Keytruda Elicits Encouraging Results in Metastatic Bladder Cancer

July 27th 2022

More than half of patients with metastatic, cisplatin-ineligible bladder cancer saw their cancer shrink when given Padcev and Keytruda in a clinical trial.

FDA to Expedite Review of Novel Drug to Treat Common Side Effect of Cancer

July 11th 2022

The FDA granted abelacimab a fast track designation for the treatment of thrombosis, a common and sometimes deadly type of blood clot associated with cancer.

Living the Full Cancer Experience With Compassion, Grace and Skill

July 2nd 2022

Backed by her personal cancer experience, an oncology nurse became a volunteer with the Bladder Cancer Advocacy Network.

FDA Permits the Study of a Novel Cancer Drug for Multiple Solid Tumors to Continue

June 30th 2022

The study the FDA allowed to continue is investigating the safety and efficacy of the novel cancer drug ACR-368 in patients with endometrial, urothelial and ovarian cancer.

Cabometyx Failed to Improve Survival in Advanced Bladder Cancer

June 4th 2022

While Cabometyx had a favorable side effect profile, it did not lead to a significant survival advantage over placebo in a clinical trial.

Cancer Trial Hopes to Find New Patient Populations That Will Respond to Already-Approved Drugs

May 19th 2022

The Strata PATH trial will use a novel testing strategy to determine if certain patients with solid tumors can benefit from already-approved therapies.

First-in-Human Trial Assessing Novel Drug in Patients With Solid Tumors Launches

May 12th 2022

The primary objective of the early-stage trial is to determine the maximum tolerated dose of the novel drug in a group of patients with recurrent and/or refractory solid tumors.

Drug Commonly Used to Treat Rare Lung Condition May Improve Survival in Patients With Bladder Cancer

April 25th 2022

Treatment with a combination of Ofev and chemotherapy was shown to have a survival benefit in a group of patients with bladder cancer.

First Patient Treated in Study to Determine Tolerability, Dosing of Investigational Drug in Certain Solid Tumors

April 22nd 2022

Once a recommended dose of the drug is determined, the study investigators will review the efficacy and safety associated with this treatment across a variety of patients with bladder and liver cancer, as well other solid tumors.

Clinical Trials Come to a ‘Disappointing’ End When Drug Combo Fails to Improve Outcomes in Kidney and Bladder Cancer

April 19th 2022

The clinical development of BEMPEG plus Opdivo will end after clinical trials showed that the drug combination did not lead to significant improvements in outcomes in patients with kidney or bladder cancer.

Clinical Trial Assessing Keytruda-Investigational Drug Combo in Head and Neck, Bladder and Lung Cancer Doses First Patient

April 13th 2022

Investigators plan to enroll approximately 90 patients with squamous cell carcinoma of the head and neck, as well as metastatic bladder and non-small cell lung cancer.

Novel Treatment Given to First Patient in Trial Assessing the Drug’s Safety and Efficacy in Solid Tumors With Certain Genetic Alterations

April 6th 2022

Researchers have treated the first patient in the PRECISION 1 trial with Fyarro to assess the drug’s efficacy across several endpoints including survival among more than 100 patients with solid tumors that exhibit certain genetic alterations.